EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company
EVERSANA is merging with Waltz Health under the EVERSANA name. Mark Thierer, co-founder and CEO of Waltz Health, will serve as the CEO of the combined company.
Serve You Rx Adds 2 Stelara Biosimilars to Formulary to Help Patients Save Costs
In partnership with Cost Plus Drugs and Waltz Health, Serve You Rx has added Stelara biosimilars Otulfi and Yesintek to its formulary.
presented by
Redefining Payer Operations: Data-Driven Strategies for the Future of Healthcare
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.
Serve You Rx Teams Up with Waltz Health to Advance Specialty Pharmacy
Through a new partnership, Serve You Rx is leveraging Waltz Health's AI-powered specialty pharmacy platform.
Waltz Health Unveils New Solution to Lower Specialty Medication Costs
Waltz Health launched Waltz Connect on Monday. The solution supports payers and aims to lower specialty drug costs.
StartUPDATES: New developments from healthcare startups
Check out new developments from Healthmine, Source Health, Amino Health, Nym Health, and Waltz Health.
Former OptumRx CEO launches startup Waltz Health with $35M, promising to lower drug costs
Pharmacy benefit managers have been widely criticized for opaque drug pricing practices. But Waltz Health, which was co-founded by former PBM executive Mark Thierer, aims to use insider knowledge and tech solutions to lower drug costs.
presented by
Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies
Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.